Shao-Ta Lu - 30 Jun 2026 Form 4 Insider Report for YD Bio Ltd (YDES)

Reporting relationship: Director
Issuer ticker: YDES
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 15:33:22 UTC
Prior SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Shao-Ta Lu

Key filing fact

Shao-Ta Lu filed Form 4 for YD Bio Ltd (YDES) on 01 Jul 2026.

Key facts

This page summarizes Shao-Ta Lu's Form 4 filing for YD Bio Ltd (YDES).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 01 Jul 2026, 15:33.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002125689 Primary reporting owner

Lu Shao-Ta

Relationship: Director
Address: C/O YD BIO LIMITED, 12F., NO. 3, XINGNAN ST., NANGANG DIST., TAIPEI CITY, TAIWAN
Signature: /s/ Shao-Ta Lu
Signature date: 01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

YDES transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +5,749
Change %: +276%
Price
Shares after: 7,830
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

YDES holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 51,151
Date: 30 Jun 2026
Ownership: By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

YDES transaction Derivative

Restricted Share Units

Award

Transaction value
Shares: +5,749
Change %
Price: $0.000000^*
Shares after: 5,749
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 5,749
Exercise price
Footnotes: F1, F2, F3

YDES transaction Derivative

Restricted Share Units

Options Exercise

Transaction value
Shares: -5,749
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 5,749
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted share unit ("RSU") represents a contingent right to receive one ordinary share, par value $0.0001 per share ("Ordinary Shares"), of YD Bio Limited.

Footnote F2

The RSUs were granted pursuant to the YD Bio Limited Equity Incentive Plan with an aggregate target grant date fair value of $60,000 on March 31, 2026 (the "Granted RSUs"). The Granted RSUs vest in four equal quarterly installments beginning March 31, 2026, with the number of RSUs subject to vesting to be determined on the applicable vesting date by dividing $15,000 by the seven (7) trading-day volume-weighted average price of the Company's Ordinary Shares ending on the trading day immediately prior to such vesting.

Footnote F3

The Reporting Person became entitled to a fixed number of RSUs on June 30, 2026 (the "Vesting Date").